Connect with us

Health

COVID-19: WHO Raises Concern over Third Wave in Africa

Published

on

Nigeria’s Response to COVID-19

By Adedapo Adesanya

The World Health Organisation (WHO) has warned that Africa is facing a fast-surging third wave of COVID-19 pandemic, with cases spreading more rapidly and projected to soon overtake the peak of the second wave the continent witnessed at the start of 2021.

The Geneva-based organisation explained that COVID-19 cases have risen for five consecutive weeks since the onset of the third wave on 3 May 2021.

Providing data as of June 20—day 48 into the new wave—Africa had recorded around 474 000 new cases—a 21 per cent increase compared with the first 48 days of the second wave. At the current rate of infections, the ongoing surge is set to surpass the previous one by early July.

A combination of factors including weak observance of public health measures, increased social interaction and movement as well as the spread of variants are powering the resurging in 12 African countries.

In the Democratic Republic of the Congo and Uganda that are experiencing COVID-19 resurgence, the Delta variant has been detected in most samples sequenced in the past month. Across Africa, the variant—first identified in India—has been reported in 14 countries.

Speaking on this, Dr Matshidiso Moeti, WHO Regional Director for Africa, “The third wave is picking up speed, spreading faster, hitting harder. With rapidly rising case numbers and increasing reports of serious illness, the latest surge threatens to be Africa’s worst yet.

“Africa can still blunt the impact of these fast-rising infections, but the window of opportunity is closing. Everyone everywhere can do their bit by taking precautions to prevent transmission.”

WHO is deploying more experts to some of the worst-affected countries, including Uganda and Zambia as well as supporting South Africa-based regional laboratories to monitor variants of concern.

WHO is also boosting innovative technological support to other laboratories in the region without sequencing capacities to better monitor the evolution of the virus. In the next six months, WHO is aiming for an eight- to ten-fold increase in the samples sequenced each month in Southern African countries.

The COVID-19 upsurge comes as the vaccine supply crunch persists. Eighteen African countries have used over 80 per cent of their COVAX vaccine supplies, with eight having exhausted their stocks. Twenty-nine countries have administered over 50 per cent of their supplies.

Despite the progress, just over 1 per cent of Africa’s population has been fully vaccinated. Globally, around 2.7 billion doses administered, of which just under 1.5 per cent have been administered in the continent.

As many high-income countries vaccinate a significant proportion of their populations, proof of vaccination is leading to fewer movement restrictions.

Globally, 16 countries are waiving quarantine for those with a vaccination certificate. Measures to prevent COVID-19 transmission are crucial, but with many African countries having limited access to vaccines, it is important that vaccines be only one of the conditions countries use to open borders and increase freedom of movement.

“With high vaccination rates, it’s shaping up into a summer of freedom, family and fun for millions of people in richer countries. This is understandable and we all long for the same joys,” said Dr Moeti.

“Vaccine shortages are already prolonging the pain of COVID-19 in Africa. Let’s not add injury to injustice. Africans must not face more restrictions because they are unable to access vaccines that are only available elsewhere. I urge all regional and national regulatory agencies to recognize all the vaccines Emergency Use listed by WHO,” she added.

In the European Union, a COVID-19 passport system for vaccination, testing and recovery will take effect from July 1. However, only four of the eight vaccines listed by WHO for emergency use are recognized by the European Medicines Agency (EMA) for the passport system.

WHO and the European Medicines Agency use the same standards in assessing vaccines. Manufacturers may choose not to apply to the European Medicines Agency if they do not intend to market their products in countries in the European Union or European Economic Area. But the safety and efficacy of all WHO emergency use listed vaccines have been proven globally in preventing severe COVID-19 illness and death.

In Africa, a WHO survey of 45 countries shows that their borders are open for air travel and only Mauritius will require proof of vaccination for international travellers from 15 July 2021. Most countries do not give quarantine exemptions for travellers who are fully vaccinated against COVID-19 and require a negative COVID-19 test.

Adedapo Adesanya is a journalist, polymath, and connoisseur of everything art. When he is not writing, he has his nose buried in one of the many books or articles he has bookmarked or simply listening to good music with a bottle of beer or wine. He supports the greatest club in the world, Manchester United F.C.

Health

VP, Governor Hail Rite Foods’ Chairman for Trauma Centre Donation to OOUTH

Published

on

Trauma Centre Donation to OOUTH

By Modupe Gbadeyanka

The chairman of Rite Foods Limited, Mr Sulaiman Adebola Adegunwa, has been commended for donating an ultra-modern Trauma Centre to the Olabisi Onabanjo University Teaching Hospital (OOUTH) in Sagamu, Ogun State.

The facility, donated to mark his 80th birthday, is a one-stop trauma centre with all the medical equipment and healthcare personnel to handle about 2,000 trauma cases in a month, from the severe to the minor ones.

Speaking at the commissioning of the 50-bedded facility, named Sulaiman Adebola Adegunwa Trauma Centre, by the Vice President of Nigeria, Mr Kashim Shettima, on Saturday, April 5, 2025, it was stated that the centre would enhance healthcare delivery for accident victims and other trauma-related cases within Ogun and neighbouring states.

Mr Shettima noted that the provision of the healthcare facility was timely, as it aligns with President Bola Ahmed Tinubu’s agenda for upgrading the health institutions in the country.

He described the life of the donor as well lived, with significant impact in the society and immediate community, creating employment for the indigenes of Ogun State, through valuable business enterprises, like Rite Foods Limited and Ess-ay Holdings Limited, which has contributed to the growth of the state’s and national economy.

According to the VP, Mr Adegunwa has inscribed his name in gold, adding that the octogenarian believes in leaving legacies that lives for generation and this has prompted the trauma centre which will impact lives tremendously.

On his part, Governor Dapo Abiodun of Ogun State applauded the philanthropic initiative of Mr Adegunwa, saying he has demonstrated an unwavering commitment to the healthcare system of Ogun State, and that the trauma centre marks a significant milestone towards attaining that.

In her remark, the Chief Medical Director of OOUTH, Dr Oluwabunmi Fatungase, said the 50 bedded centre has been the desire of the management of the hospital, as the old 20 bedded accident and emergency centre is too small to accommodate accident victims within the state, which serves as a route for travellers traversing the different regions of the country, with a 41.5 percent accident rate.

She said it is a dream of over 20 years by various administrations come true as there is no General Hospital from Lagos to Benin and Ibadan to take care of accident victims, thereby making the trauma centre a well thought out project by Asiwaju Adegunwa.

On his part, Mr Adegunwa said, “Today, l am filled with immense joy as l reflect on Sulaiman Adebola Adegunwa Trauma Centre as another fulfilment of opportunity to serve a higher calling to give and serve.”

Continue Reading

Health

Iwosan Investments, Mayo Clinic to Deliver World-class Healthcare Services

Published

on

Iwosan Investments

By Modupe Gbadeyanka

A partnership to advance high-quality patient-centred healthcare in Nigeria has been entered into between Iwosan Investments Limited and Mayo Clinic Global Consulting.

The aim is to advise and support Iwosan in delivering world-class healthcare services that will positively impact both local and regional communities.

This includes the enhancement of Iwosan’s hospital network starting with Iwosan Lagoon Hospitals and the development and integration of the Lagos Medipark Hospital.

Mayo Clinic Global Consulting will to provide strategic advice on organizational objectives and clinical practice.

Under the consulting contract, Iwosan will work with Mayo Clinic experts on several projects to advance high-quality, patient-centred healthcare in Nigeria.

Mayo Clinic is a global leader in serious and complex healthcare. Mayo Clinic Global Consulting is designed to share Mayo Clinic’s unique, comprehensive capabilities and knowledge.

The focus of this engagement is to help the Iwosan network improve administrative efficiencies and effectiveness and to enhance medical practice and patient care through the application of Mayo Clinic’s integrated clinical care and practice models.

 “This marks a significant milestone in our commitment to delivering exceptional healthcare services to the people of Nigeria.

“With guidance from Mayo Clinic Global Consulting, we are confident in our ability to set new benchmarks in healthcare excellence in our region,” the chief executive of Iwosan Investments, Mrs Fola Laoye, stated.

Iwosan Investments is a healthcare investment company with an ongoing commitment to revolutionize healthcare delivery in Nigeria.

Continue Reading

Health

NAFDAC Intensifies Efforts to Block Substandard Products from China, India

Published

on

Medication Drugs

By Adedapo Adesanya

The National Agency for Food and Drug Administration and Control (NAFDAC) is increasing efforts to block the entry of substandard and counterfeit products into Nigeria, particularly from China and India, the country’s two largest pharmaceutical trade partners.

This was revealed by Mrs Mojisola Adeyeye, the Director-General of the agency, emphasised that the Clean Report of Inspection and Analysis (CRIA) scheme has significantly strengthened regulatory control over imports from these nations.

The two nation’s account for 60 per cent of Nigeria’s pharmaceutical imports and yet, there is a lot of counterfeit and substandard medicines from these countries.

She said, “Because most of these drugs come from China and India, the CRIA scheme is operational in those two countries,” adding that, “It ensures that only safe and high-quality products are shipped while preventing the export of substandard and counterfeit products.”

She note that NAFDAC has appointed and accredited CRIA agents in China and India to conduct rigorous pre-shipment inspections to tackle the issue.

In addition to appointing CRIA agents in China and India, NAFDAC is collaborating with COTECNA, a global testing, inspection, and certification service provider, to enhance quality control measures.

Mrs Adeyeye urged stakeholders to engage with these CRIA agents before shipping any consignment to Nigeria, saying, “I strongly encourage you to engage with CRIA agents before shipping any consignment–that is, to our stakeholders– from China, India, or Nigeria. You have the flexibility to choose from any of the listed CRIA agents to ensure compliance and safeguard the quality of imported products.”

NAFDAC also introduced an electronic platform, the Port Inspection Data Capture and Risk Management System (PIDCARMS), to enhance document verification and streamline inspection processes.

Mrs Adeyeye noted that CRIA agents will ensure that rejected shipments carrying drugs will not find their way to the country.

She urged stakeholders to visit NAFDAC’s official website for guidelines on product registration, labelling, and shipment requirements to ensure compliance with regulatory standards in order to prevent such lapses and ensure only approved products enter Nigeria.

Continue Reading

Trending